Evercore ISI Group Initiates Coverage On Foghorn Therapeutics With Outperform Rating, Announces Price Target of $20
Evercore ISI Group Initiates Coverage On Foghorn Therapeutics With Outperform Rating, Announces Price Target of $20
Evercore ISI Group發表報告，對Foghorn Therapeutics進行覆蓋研究，評級爲跑贏大市，目標價20美元。
Evercore ISI Group analyst Gavin Clark-Gartner initiates coverage on Foghorn Therapeutics (NASDAQ:FHTX) with a Outperform rating and announces Price Target of $20.
Evercore ISI Group分析師Gavin Clark-Gartner 以「跑贏大盤」的評級開啓對foghorn therapeutics（納斯達克:FHTX）的覆蓋，並宣佈目標價爲20美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。